Bharat Biotech Arm Nucelion, VeGen Bio to Partner for CAR-T Therapy

Bharat Biotech’s CRDMO Nucelion Partners VeGen Bio to develop India’s first dual-target CAR-T cell therapy

Bharat Biotech’s Nucelion partners VeGen Bio to develop and manufacture India’s first dual-target CAR-T VL-2511 for myeloma, aiming trials and 2028 launch.

BharatBiotech’s Nucelion Therapeutics Partners with VeGen Bio to Build India’s First Dual-Target Myeloma CAR-T

Get latest articles and stories on India at LatestLY. Hyderabad-based Nucelion Therapeutics Pvt. Ltd. (“Nucelion”), a subsidiary of Bharat Biotech, a specialised cell and gene therapy Contract Research, Development, and Manufacturing Organisation (CRDMO), and VeGen Bio Pvt. Ltd. (“VeGen Bio” / “VeGen Labs”), a Hyderabad-based precision oncology company, today announced a strategic collaboration for the technology transfer, clinical manufacturing…

Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy

Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma

Nucelion and VeGen Bio partner to manufacture CAR-T therapy in India

The collaboration will combine technology transfer, clinical and commercial manufacturing, and process optimisation to improve production economics and expand patient access

Nucelion, VeGen Bio Target Lower Manufacturing Costs for Next Generation Cell Therapies

Hyderabad, October 22, 2026: Nucelion Therapeutics, a wholly owned subsidiary of Bharat Biotech, has entered into a strategic collaboration with Hyderabad based precision oncology company VeGen Bio to support the technology transfer, clinical manufacturing and commercial production of VL 2511, an investigational CAR T cell therapy for multiple myeloma. The partnership will bring VeGen Bio’s […]

Nucelion Therapeutics, VeGen Bio collaborate on CAR-T cell therapy manufacturing

The partnership will cover technology transfer, clinical manufacturing and commercial production of VeGen Bio’s VL-2511 in India